| scholarly article | Q13442814 |
| P356 | DOI | 10.1096/FJ.03-0978FJE |
| P698 | PubMed publication ID | 15033922 |
| P50 | author | Patrick R Hof | Q90342606 |
| Lap Ho | Q60418097 | ||
| P2093 | author name string | Jun Wang | |
| Weiping Qin | |||
| Giulio Maria Pasinetti | |||
| Zhong Zhao | |||
| Charles V Mobbs | |||
| Zhongmin Xiang | |||
| Yuanzhen Peng | |||
| Anne Rocher | |||
| Patrick N Pompl | |||
| Gina Cambareri | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 902-904 | |
| P577 | publication date | 2004-03-19 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease | |
| P478 | volume | 18 |
| Q34811570 | A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models |
| Q48407108 | A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin |
| Q24816672 | A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease |
| Q22242399 | A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment |
| Q26771808 | A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease |
| Q90220614 | APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice |
| Q45920578 | Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease. |
| Q36478423 | Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis |
| Q33757617 | Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice |
| Q90003697 | Ageing as a risk factor for neurodegenerative disease |
| Q36410706 | Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway |
| Q38177975 | Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles |
| Q53329640 | Alzheimer disease: Insulin resistance and AD--extending the translational path. |
| Q55353865 | Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. |
| Q28086892 | Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms |
| Q26864965 | Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions |
| Q35084406 | Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation. |
| Q34140538 | Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity |
| Q38678160 | Amyloid precursor protein in pancreatic islets. |
| Q35976702 | Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway |
| Q36720621 | Amyloid-β induces hepatic insulin resistance in vivo via JAK2. |
| Q36512147 | Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. |
| Q47731042 | Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes |
| Q37220627 | Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET. |
| Q84875066 | Association between the RAGE G82S polymorphism and Alzheimer's disease |
| Q47906366 | Astragalus membranaceus-Polysaccharides Ameliorates Obesity, Hepatic Steatosis, Neuroinflammation and Cognition Impairment without Affecting Amyloid Deposition in Metabolically Stressed APPswe/PS1dE9 Mice |
| Q98945320 | Beneficial Effect of Genistein on Diabetes-Induced Brain Damage in the ob/ob Mouse Model |
| Q34884241 | Bidirectional metabolic regulation of neurocognitive function |
| Q26830098 | Body fluid biomarkers in Alzheimer's disease |
| Q37025645 | Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development |
| Q38253639 | Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms |
| Q38075505 | Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. |
| Q27012801 | Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs |
| Q37930196 | Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes |
| Q90701325 | Broadening the definition of brain insulin resistance in aging and Alzheimer's disease |
| Q35130936 | Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia |
| Q38542045 | Can insulin signaling pathways be targeted to transport Aβ out of the brain? |
| Q38688226 | Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease |
| Q42185326 | Childhood and adolescent obesity and long-term cognitive consequences during aging. |
| Q26738964 | Chronic over-nutrition and dysregulation of GSK3 in diseases |
| Q37270464 | Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. |
| Q48296620 | Cognitive impairment is correlated with insulin resistance degree: the "PA-NICO-study". |
| Q38828830 | Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease |
| Q37231564 | Concurrence of High Fat Diet and APOE Gene Induces Allele Specific Metabolic and Mental Stress Changes in a Mouse Model of Alzheimer's Disease |
| Q35687048 | Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease |
| Q34984057 | Continuation of exercise is necessary to inhibit high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice |
| Q37295166 | Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice |
| Q34805939 | Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. |
| Q36073458 | Crosstalk between metabolic and neuropsychiatric disorders |
| Q35053868 | DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects |
| Q28505715 | Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice |
| Q35858095 | Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline |
| Q26750648 | Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models |
| Q27022552 | Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress |
| Q90319593 | Diabetes and Alzheimer's Disease: A Link not as Simple as it Seems |
| Q58590774 | Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects |
| Q28543410 | Diabetes mellitus accelerates Aβ pathology in brain accompanied by enhanced GAβ generation in nonhuman primates |
| Q33859600 | Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes |
| Q47580576 | Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function |
| Q37417661 | Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology |
| Q58566963 | Dietary patterns and β-amyloid deposition in aging Australian women |
| Q64120150 | Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease |
| Q38733357 | EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease. |
| Q30559265 | Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial |
| Q27001244 | Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer's disease (review) |
| Q57821847 | Effects of aging, high-fat diet, and testosterone treatment on neural and metabolic outcomes in male brown Norway rats |
| Q45307020 | Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque. |
| Q37375685 | Effects of glucose and insulin on secretion of amyloid-β by human adipose tissue cells |
| Q92640130 | Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge |
| Q28710367 | Energy intake and exercise as determinants of brain health and vulnerability to injury and disease |
| Q38828060 | Energy metabolism and inflammation in brain aging and Alzheimer's disease. |
| Q41547214 | Erythrocytes as Potential Link between Diabetes and Alzheimer's Disease |
| Q36080477 | Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice |
| Q38641542 | Filling the void: a role for exercise induced BDNF and brain amyloid precursor protein processing |
| Q27009988 | Food for thought: the role of appetitive peptides in age-related cognitive decline |
| Q30619452 | GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals |
| Q34189447 | Gene-environment interaction research and transgenic mouse models of Alzheimer's disease |
| Q33932945 | Genetic polymorphisms of a novel vascular susceptibility gene, Ninjurin2 (NINJ2), are associated with a decreased risk of Alzheimer's disease |
| Q90718287 | GluT4: A central player in hippocampal memory and brain insulin resistance |
| Q35070673 | Glucagon-like peptide-1, diabetes, and cognitive decline: possible pathophysiological links and therapeutic opportunities. |
| Q24685475 | Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics |
| Q36605311 | Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice |
| Q53466284 | Glycogen synthase kinase-3 regulates production of amyloid-β peptides and tau phosphorylation in diabetic rat brain. |
| Q30492766 | Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease |
| Q30494177 | Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration |
| Q35790526 | High Fat Diet Enhances β-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting β-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation. |
| Q30586174 | High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice |
| Q58798270 | High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse model |
| Q33624475 | High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology |
| Q92476716 | Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life |
| Q40803943 | Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance |
| Q33710643 | Human cerebral neuropathology of Type 2 diabetes mellitus |
| Q37135881 | Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling |
| Q49659203 | Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. |
| Q37083944 | Impact of energy intake and expenditure on neuronal plasticity |
| Q51283041 | Impact of enriched environment on production of tau, amyloid precursor protein and, amyloid-β peptide in high-fat and high-sucrose-fed rats. |
| Q34700226 | Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease |
| Q47548856 | Impairment of Novel Object Recognition Memory and Brain Insulin Signaling in Fructose- but Not Glucose-Drinking Female Rats |
| Q48674609 | Impairment of the glymphatic system after diabetes |
| Q33772344 | Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model |
| Q37760979 | Increased fructose intake as a risk factor for dementia |
| Q26773657 | Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease |
| Q33687072 | Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease |
| Q40343183 | Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease |
| Q46799102 | Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages |
| Q39042377 | Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease |
| Q63805071 | Insulin Resistance and Oxidative Stress in the Brain: What's New? |
| Q33628048 | Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease |
| Q34468797 | Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers |
| Q37343162 | Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults |
| Q37689883 | Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets |
| Q35674377 | Insulin and neurodegenerative disease: shared and specific mechanisms |
| Q38234927 | Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia |
| Q41722230 | Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model |
| Q46852229 | Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. |
| Q21296648 | Insulin in central nervous system: more than just a peripheral hormone |
| Q26866392 | Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease |
| Q26825385 | Insulin in the brain: there and back again |
| Q28079442 | Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood |
| Q42082363 | Insulin receptor expression and activity in the brains of nondiabetic sporadic Alzheimer's disease cases |
| Q36528274 | Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease |
| Q34622157 | Insulin resistance in Alzheimer's disease |
| Q89414089 | Insulin resistance in Alzheimer's disease |
| Q38603015 | Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. |
| Q34429975 | Insulin resistance predicts brain amyloid deposition in late middle-aged adults. |
| Q33604874 | Insulin, cognition, and dementia |
| Q43477250 | Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. |
| Q34669518 | Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? |
| Q46945608 | Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. |
| Q38515285 | Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. |
| Q28394967 | Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors |
| Q34020532 | Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. |
| Q30573779 | Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice |
| Q47144533 | Intrahippocampal administration of amyloid-β(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism |
| Q48823757 | Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy |
| Q57777652 | Intraneuronal -Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response |
| Q38938961 | Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal |
| Q34795761 | Ketone bodies as a therapeutic for Alzheimer's disease |
| Q38561865 | Linking insulin with Alzheimer's disease: emergence as type III diabetes |
| Q91773883 | Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism |
| Q60915852 | Maternal Cognitive Impairment Associated with Gestational Diabetes Mellitus-A Review of Potential Contributing Mechanisms |
| Q33740362 | Maternal high-fat diet worsens memory deficits in the triple-transgenic (3xTgAD) mouse model of Alzheimer's disease |
| Q43590947 | Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice |
| Q55090853 | Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer's Disease Prevention. |
| Q28551718 | Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment |
| Q26799893 | Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment |
| Q33579072 | Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons |
| Q24654247 | Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease |
| Q90715173 | Modeling glymphatic system of the brain using MRI |
| Q26783344 | Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal |
| Q34914164 | Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus |
| Q35831048 | Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model |
| Q60168083 | Neuroenergetics of traumatic brain injury |
| Q27694676 | Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms |
| Q24646914 | Neuroprotective and disease-modifying effects of the ketogenic diet |
| Q38118901 | Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease |
| Q33783000 | New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders |
| Q47657818 | Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice |
| Q64240263 | Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways |
| Q61800105 | Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders |
| Q33791780 | Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice. |
| Q38680759 | Obesity and sex interact in the regulation of Alzheimer's disease |
| Q34229644 | Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease |
| Q36587781 | Obesity, leptin, and Alzheimer's disease |
| Q37215869 | PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease |
| Q48497036 | PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus. |
| Q33556064 | Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation |
| Q47218201 | Palmitate induced C/EBP homologous protein activation leads to NF-κB -mediated increase in BACE1 activity and Amyloid beta genesis. |
| Q42540801 | Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease |
| Q47593479 | Perspectives of Alzheimer's disease treatments |
| Q33573142 | Phosphokinase antibody arrays on dendron-coated surface. |
| Q34338701 | Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. |
| Q33674777 | Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation |
| Q46734353 | Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats |
| Q37857377 | Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis |
| Q36455500 | Pre-training Catechin gavage prevents memory impairment induced by intracerebroventricular streptozotocin in rats |
| Q43796039 | Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse |
| Q28308082 | Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers |
| Q37463231 | Protective Effect of Genistein against Neuronal Degeneration in ApoE-/- Mice Fed a High-Fat Diet |
| Q93163161 | Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer's disease |
| Q38034108 | Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease |
| Q39750857 | Reduced cortical BACE1 content with one bout of exercise is accompanied by declines in AMPK, Akt, and MAPK signaling in obese, glucose-intolerant mice. |
| Q35623033 | Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. |
| Q37020746 | Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration |
| Q50103147 | Relationship of Type 2 Diabetes to Human Brain Pathology |
| Q33789329 | Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease |
| Q33886222 | Reversal of diabetic nephropathy by a ketogenic diet. |
| Q38268394 | Role of insulin resistance in Alzheimer's disease. |
| Q34055011 | Role of vascular risk factors and vascular dysfunction in Alzheimer's disease |
| Q30471693 | Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status |
| Q35036518 | Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease |
| Q26784170 | Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline |
| Q58699276 | Signaling Mechanisms of Selective PPAR Modulators in Alzheimer's Disease |
| Q38782180 | Similarities and interactions between the ageing process and high chronic intake of added sugars |
| Q24303857 | Sirtuin functions in health and disease |
| Q51373857 | Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4 |
| Q38904883 | Sweet old memories: a review of the experimental models of the association between diabetes, senility and dementia |
| Q38268535 | Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases. |
| Q43252220 | The 6th Annual World Congress on the Insulin Resistance Syndrome. |
| Q37379621 | The Association between Impaired Glucose Regulation and Prognosis of Chinese Patients with Intracerebral Hemorrhage |
| Q35327219 | The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease |
| Q59133635 | The Glymphatic System in Diabetes-Induced Dementia |
| Q55411317 | The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease. |
| Q89509291 | The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions |
| Q35588860 | The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment |
| Q51377992 | The effects of a cafeteria diet on insulin production and clearance in rats. |
| Q37112633 | The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid |
| Q34657827 | The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective |
| Q33600053 | The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease |
| Q38736271 | The rise and fall of insulin signaling in Alzheimer's disease |
| Q37029352 | The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications |
| Q26777969 | The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease |
| Q28742884 | The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice |
| Q33828868 | Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice |
| Q33857774 | Type 2 diabetes as a risk factor for cognitive impairment: current insights |
| Q35866744 | Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance |
| Q36616575 | Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1 |
| Q41951938 | Use of copper and insulin-resistance to accelerate cognitive deficits and synaptic protein loss in a rat Abeta-infusion Alzheimer's disease model |
| Q24675823 | Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease |
| Q60693597 | Western Style Diet Impairs Entrance of Blood-Borne Insulin-like Growth Factor-1 into the Brain |
| Q50769472 | aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease. |
Search more.